In partnership with the Blind Veterans UK, Circadian Therapeutics is conducting a research study to explore the sleep and circadian disruption experienced by vision impaired individuals.

Our study aims to improve treatment pathways and provide informed feedback to the Visually Impaired community about improving sleep and circadian rhythms.

Participate in our Online Sleep Survey

We are actively recruiting individials with vision impairment for our Online Sleep Survey.

To take part in the study, please follow the link below to register your name and contact details and a researcher will get in touch with you directly.

The survey is open to adults over the age of 18 who live in the UK and who are registered as sight impaired or severely sight impaired. The Survey takes 45 – 60 minutes to complete and can be completed online, or over the telephone with one of our friendly researchers. There is currently no cut-off date for completing the survey.

The learn more about the Survey, visit our Survey Page.

To get in contact with the Research Team, visit our Contact Page.

A Testimonial from one of our Participants

“I volunteered to take part in the study because I believe research into vision impairment is very important and relevant. I wanted to be able to help in some way, to be useful to those in the future that may face the same issues that I face and in a sense it gave me a way to continue to serve. I enjoyed being able to come down to the Blind Veterans UK office and meet the staff who I don’t usually get to speak to face to face. Being able to meet and work with the research team was great – they are a great group of people. I was hugely impressed with the scientists that I worked with, they are fantastic people who explained everything to me clearly, made sure that I knew what was going on at all times and were just very easy to get along with. I can’t understand why more people don’t get involved with research!”

– A blind veteran taking part in the study

This project has been reviewed and received favourable opinion by the Health Research Authority and Research Ethics Committee (REC reference: 18/WM/0290)